Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00439816
Other study ID # LIP 82-003
Secondary ID HR 11260
Status Completed
Phase N/A
First received February 22, 2007
Last updated April 6, 2015
Start date February 2005
Est. completion date September 2007

Study information

Verified date November 2007
Source VA Office of Research and Development
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

To determine racial/ethnic differences in preference for group visits in veterans with poorly controlled hypertension (State 2 hypertension) and determine the effect of group visits on health outcomes among veterans with poorly controlled hypertension.


Description:

Research Design: Randomized clinical trial to assess veterans� preference for group visits and the effect of group visits on hypertension outcomes. Hypertension affects close to 50 million persons in the U.S., with prevalence, severity, and impact being increased in non-white Americans 1.Despite recent clinical trials associating successful antihypertensive therapy with reductions in stroke incidence, myocardial infarction, and heart failure, control rates remain below the Healthy People 2010 goal of 50%. The importance of blood pressure control is recognized within the VA as two of the conditions selected for QUERI include ischemic heart disease and congestive heart disease, and blood pressure control is a performance measure for every VAMC 2. Clinical trials have shown that blood pressure control can be achieved in most patients with hypertension 3. When physicians fail to prescribe lifestyle modification, adequate doses of antihypertensive medications, or appropriate drugs, blood pressure control may not be achieved.1 In the course of a 15-30 minute visit with a primary care physician, lifestyle modifications may not be addressed and inertia may prevent rapid adjustments in medication dosages or changes in drug combinations. 4. The outpatient group visit model is an intervention developed by managed care organizations to capitalize on economy of scale. It has significant points of departure from the existing health care delivery system design, which focuses on acute care. The outpatient group visit model also fosters a more collaborative effort between the physician and patient, introduces nurses as knowledgeable team members who can be trusted to communicate important information to patients and between patients and physicians, and promotes peer support among the participating patients. Group visits have proven successful in high health services utilizing elderly patients with one or more chronic illnesses. A one-year study of monthly 2-hour group visits led by a physician and nurse showed significant improvements in care delivery as measured by decreases in emergency room visits, specialty care visits, and hospital readmissions though no change in self-reported health and functional status were realized. 5. Also, patients with type 2 diabetes attending group visits were shown to have increases in quality of life measures, knowledge of type 2 diabetes, and improved metabolic control as compared to patients in usual care. 6. Group visits offer providers more time per visit to address process-of-care indicators and provide patients more time per visit with their primary care physician. The monthly schedule allows for more frequent contacts between the patients and physicians. Providers caring for patients in groups can deliver consistent messages to multiple patients at once. Though monthly primary care visits (in groups) would be an increase from the 4 primary care visits per year presently realized by veterans with hypertension at the Ralph H. Johnson VAMC, the frequency is more consistent with JNC 7 guidelines for monthly visits for follow-up and monitoring after the initiation of antihypertensive therapy. Presently, the average primary care physician at the Charleston VA is scheduled to see 2 patients per hour. Group visits would allow the physician to see 20 patients over 2 hours. While demonstrated feasible and acceptable to elderly, chronically ill managed care populations, and uninsured and underinsured patients with type 2 diabetes, group visits have not been systematically tested in the Veteran�s Health Administration system. Additionally, previous studies have not evaluated patients� acceptance of group visits or their responses to groups according to race/ethnicity. This study seeks to inform whether group visits are acceptable to veterans as a method of health care delivery, regardless of race/ethnicity.

Methods: The study will assess the effect of group visits on hypertension outcomes. Veterans with stage 2 hypertension (systolic blood pressure =160 mmHg or diastolic blood pressure =100 mmHg) will be identified during routine office visits. The primary care physician will explain what group visits are using a standard script then patients will be asked if they are willing to be seen in a group setting. Patients who indicate a willingness to receive care in a group setting will be randomly assigned to either group visits or usual care. Randomization will occur in blocks to insure equal number of subjects by race/ethnicity in each of the two groups (group setting vs. usual care). We will recruit up to 8 VA primary care physicians to participate in this study. Several have already indicated an interest in conducting group visits.

Patient Visit Protocol: Group visits will be co-led by the patients� primary care internal medicine physician and a clinic nurse. Each group visit session will be scheduled for two hours consisting of: 15 minutes for "warm-up" and socialization, 30 minutes for presentation of a health- related topic (facilitated by the physician or another team member with special expertise), 15 minutes for break, during which time the nurse and physician will circulate, attending to individual needs, immunizations, appointment scheduling, and other issues, 15 minutes for questions and answers, 15 minutes for planning the next session, and 30 minutes for one-on-one consultations with the physician. Upon conclusion of the group portion of the visit, patients will have the opportunity to see the physician individually if required. While the group visits are intended to be the main source of medical care, patients who need care in between scheduled group visits, or who have specific medical needs that cannot be accommodated in the group visit (i.e. PAP smears, DRE), will be able to schedule a one-on-one visit with their primary care provider.


Recruitment information / eligibility

Status Completed
Enrollment 160
Est. completion date September 2007
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 21 Years and older
Eligibility Inclusion Criteria:

Caucasian and African American men and women, age 21 and older with stage 2 hypertension presently seen in the RHJ VAMC Primary Care.

Exclusion Criteria:

Primary diagnosis of substance abuse or dependence, current pregnancy, dementia, inability to speak English, or controlled psychiatric diagnoses.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Group Visits


Locations

Country Name City State
United States Ralph H. Johnson VA Medical Center, Charleston, SC Charleston South Carolina

Sponsors (1)

Lead Sponsor Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States, 

References & Publications (2)

Davis KS, Magruder KM, Lin Y, Powell CK, Clancy DE. Brief report: Trainee provider perceptions of group visits. J Gen Intern Med. 2006 Apr;21(4):357-9. — View Citation

Wager KA, Ward DM, Lee FW, White AW, Davis KS, Clancy DE. Physicians, Patients, and EHRs. When it comes to a consultation, is three a crowd? J AHIMA. 2005 Apr;76(4):38-41. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Blood pressure control. Medication compliance (as measured by refill histories). Health services utilization patterns (as defined by days in hospital, outpatient visits and urgent care visits). No
Secondary Acceptability of group visits to White and African American veterans, measured by comparing proportion of those who agreed to participate in groups to those who didn't. The attendance rates by patient race/ethnicity among those assigned to group visits. No
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A